Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$7.26
+0.8%
$9.31
$2.09
$14.84
$514.66M0.055.32 million shs2.25 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$204.41
-0.5%
$229.40
$180.93
$348.67
$7.91B0.51342,252 shs290,640 shs
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
$18.99
+0.7%
$23.31
$18.66
$29.35
N/A0.72238,545 shs442,337 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
+1.69%+4.50%-16.76%-22.83%+37.93%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.32%+1.74%-6.97%-18.57%-27.69%
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
-2.26%-4.63%-17.16%-25.97%-35.34%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
1.358 of 5 stars
3.31.00.00.03.11.70.0
Penumbra, Inc. stock logo
PEN
Penumbra
4.8751 of 5 stars
4.41.00.03.82.72.53.1
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$15.00106.61% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.78
Moderate Buy$304.4548.94% Upside
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
2.00
HoldN/AN/A

Current Analyst Ratings

Latest ODA, ALT, PEN, IHR, and TLK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Penumbra, Inc. stock logo
PEN
Penumbra
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$290.00
4/1/2024
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
3/22/2024
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$290.00 ➝ $280.00
2/23/2024
Penumbra, Inc. stock logo
PEN
Penumbra
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$310.00 ➝ $290.00
2/23/2024
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$289.00
2/23/2024
Penumbra, Inc. stock logo
PEN
Penumbra
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$284.00
2/23/2024
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$300.00 ➝ $290.00
2/23/2024
Penumbra, Inc. stock logo
PEN
Penumbra
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$284.00 ➝ $250.00
2/13/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$430K1,196.89N/AN/A$2.75 per share2.64
Penumbra, Inc. stock logo
PEN
Penumbra
$1.06B7.47$2.80 per share72.90$30.55 per share6.69
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
$9.80BN/A$1.59 per share11.96$10.63 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$90.95M$2.3188.4951.362.048.59%7.49%5.60%5/7/2024 (Confirmed)
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
$1.59B$1.6911.2410.851.8016.12%16.77%8.94%4/26/2024 (Estimated)

Latest ODA, ALT, PEN, IHR, and TLK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Penumbra, Inc. stock logo
PEN
Penumbra
$0.42N/A-$0.42N/AN/AN/A  
3/27/2024Q4 2023
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.33+$0.02-$0.12N/A$0.04 million
3/22/2024Q4 2023
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
N/A$0.33+$0.33$0.33N/A$2.43 billion  
2/22/2024Q4 2023
Penumbra, Inc. stock logo
PEN
Penumbra
$0.71$0.76+$0.05$0.14$286.62 million$284.68 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
$0.854.48%+13.03%50.30%3 Years

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
17.26
17.26
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.06
3.49
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
0.16
0.87
0.85

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5970.89 million67.99 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,20038.70 million36.65 millionOptionable
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk stock logo
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
23,064N/AN/ANot Optionable

ODA, ALT, PEN, IHR, and TLK Headlines

SourceHeadline
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk GAAP EPS of Rp 64.85, revenue of Rp 37429BPerusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk GAAP EPS of Rp 64.85, revenue of Rp 37429B
seekingalpha.com - April 23 at 2:02 PM
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) Sets New 1-Year Low at $19.47Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) Sets New 1-Year Low at $19.47
americanbankingnews.com - April 21 at 1:42 AM
StockNews.com Upgrades Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) to BuyStockNews.com Upgrades Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) to Buy
americanbankingnews.com - April 20 at 2:14 AM
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) Sets New 52-Week Low at $19.47Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) Sets New 52-Week Low at $19.47
marketbeat.com - April 19 at 10:52 AM
Telekomunikasi Indonesia: Sell-Off Looks OverdoneTelekomunikasi Indonesia: Sell-Off Looks Overdone
seekingalpha.com - April 18 at 9:45 AM
PT Telkom Indonesia (Persero) Tbk 2023 Annual Report on Form 20-FPT Telkom Indonesia (Persero) Tbk 2023 Annual Report on Form 20-F
prnewswire.com - April 2 at 8:00 AM
Telekomunikasi Indonesia ADRTelekomunikasi Indonesia ADR
wsj.com - March 23 at 2:11 AM
TLK or SCMWY: Which Is the Better Value Stock Right Now?TLK or SCMWY: Which Is the Better Value Stock Right Now?
zacks.com - March 11 at 12:41 PM
TLK vs. SCMWY: Which Stock Is the Better Value Option?TLK vs. SCMWY: Which Stock Is the Better Value Option?
zacks.com - February 22 at 12:41 PM
Telkom Indonesia looking to sell stake in data centre business, to conclude deal by H2Telkom Indonesia looking to sell stake in data centre business, to conclude deal by H2
finance.yahoo.com - February 6 at 6:18 AM
Telekomunikasi Indonesia: A Buy For The Short Term And The Long RunTelekomunikasi Indonesia: A Buy For The Short Term And The Long Run
seekingalpha.com - February 4 at 5:40 AM
Telkom Indonesia (TLKM) Konfirmasi Pengunduran Diri Abdee SlankTelkom Indonesia (TLKM) Konfirmasi Pengunduran Diri Abdee Slank
msn.com - January 20 at 7:28 AM
Telekomunikasi Indonesia: Many Things To LikeTelekomunikasi Indonesia: Many Things To Like
seekingalpha.com - November 20 at 4:12 PM
Telekomunikasi Indonesia: Eyes On Potential Value Unlocking Corporate ActionsTelekomunikasi Indonesia: Eyes On Potential Value Unlocking Corporate Actions
seekingalpha.com - September 5 at 8:34 AM
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk 2023 Q2 - Results - Earnings Call PresentationPerusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk 2023 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 10 at 8:09 AM
Telkom Indonesia (Persero) Tbk PT - ADR (TLK) Price Target Decreased by 9.83% to 25.10Telkom Indonesia (Persero) Tbk PT - ADR (TLK) Price Target Decreased by 9.83% to 25.10
msn.com - August 3 at 5:31 PM
Telkom Indonesia Bukukan Pendapatan Rp73,5 Triliun Semester I/2023Telkom Indonesia Bukukan Pendapatan Rp73,5 Triliun Semester I/2023
asiatoday.id - July 29 at 12:33 AM
Timah Persero Tbk (TINS)Timah Persero Tbk (TINS)
investing.com - July 25 at 1:32 AM
Memasuki Usia 58, Telkom Indonesia (TLKM) Fokus Pada Industri B2B dan Solusi DigitalMemasuki Usia 58, Telkom Indonesia (TLKM) Fokus Pada Industri B2B dan Solusi Digital
msn.com - July 6 at 1:18 AM
Telkom Indonesia Resmi Integrasikan IndiHome ke TelkomselTelkom Indonesia Resmi Integrasikan IndiHome ke Telkomsel
liputan6.com - June 27 at 12:57 PM
Telekomunikasi Indonesia: Staying Bullish On Positive Long-Term OutlookTelekomunikasi Indonesia: Staying Bullish On Positive Long-Term Outlook
seekingalpha.com - June 21 at 3:55 AM
Telkom Indonesia Gandeng Expereo Perluas Jangkauan GlobalTelkom Indonesia Gandeng Expereo Perluas Jangkauan Global
asiatoday.id - June 19 at 5:14 AM
TLKM.JK - Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia TbkTLKM.JK - Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
au.finance.yahoo.com - June 13 at 7:59 AM
TLKMF - Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia TbkTLKMF - Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk
finance.yahoo.com - June 13 at 7:59 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altimmune logo

Altimmune

NASDAQ:ALT
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Penumbra logo

Penumbra

NYSE:PEN
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk logo

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk

NYSE:TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides information and communications technology, and telecommunications network services worldwide. The company operates through mobile, consumer, enterprise, Wholesale and International Business, and Other segments. The Mobile segment offers mobile voice, SMS, value added services, and mobile broadband services. The Consumer segment provides fixed wireline, pay TV, and internet services; and other telecommunication services to home customers. The Enterprise segment offers end-to-end solution to corporate and institutions. The Wholesale and International Business segment provides interconnection services, broadband access, information technology services, data, and internet services to other licensed operator and institutions. The Other segment offers digital content products, big data, business to business commerce, and financial services to individual and corporate customers. The company also engages in leasing of towers, and digital support and other telecommunication services; provision of consultation service of hardware, computer software, and data center, as well as multimedia portal services; business management consulting; property development and management; trading service related to telecommunication, information, multimedia technology, entertainment, and investment; and digital content exchange hub services. The company was founded in 1884 and is headquartered in Bandung, Indonesia.